nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—CHRM3—muscle of abdomen—skin cancer	0.135	0.357	CbGeAlD
Trihexyphenidyl—CHRM5—skin epidermis—skin cancer	0.0884	0.233	CbGeAlD
Trihexyphenidyl—Weight decreased—Vismodegib—skin cancer	0.0314	0.0506	CcSEcCtD
Trihexyphenidyl—CHRM5—epithelium—skin cancer	0.0288	0.0759	CbGeAlD
Trihexyphenidyl—CHRM5—skin of body—skin cancer	0.0274	0.0722	CbGeAlD
Trihexyphenidyl—CHRM4—head—skin cancer	0.0229	0.0603	CbGeAlD
Trihexyphenidyl—Dry skin—Vemurafenib—skin cancer	0.0227	0.0366	CcSEcCtD
Trihexyphenidyl—Memory impairment—Temozolomide—skin cancer	0.0223	0.0358	CcSEcCtD
Trihexyphenidyl—Weight decreased—Vemurafenib—skin cancer	0.0194	0.0312	CcSEcCtD
Trihexyphenidyl—CHRM5—head—skin cancer	0.0179	0.0471	CbGeAlD
Trihexyphenidyl—Constipation—Vismodegib—skin cancer	0.0169	0.0272	CcSEcCtD
Trihexyphenidyl—Asthenia—Vismodegib—skin cancer	0.0142	0.0228	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Fluorouracil—skin cancer	0.0138	0.0223	CcSEcCtD
Trihexyphenidyl—CHRM1—female reproductive system—skin cancer	0.0134	0.0352	CbGeAlD
Trihexyphenidyl—Vomiting—Vismodegib—skin cancer	0.0125	0.0202	CcSEcCtD
Trihexyphenidyl—Rash—Vismodegib—skin cancer	0.0124	0.02	CcSEcCtD
Trihexyphenidyl—Dermatitis—Vismodegib—skin cancer	0.0124	0.02	CcSEcCtD
Trihexyphenidyl—CHRM2—head—skin cancer	0.0123	0.0323	CbGeAlD
Trihexyphenidyl—CHRM3—female reproductive system—skin cancer	0.012	0.0315	CbGeAlD
Trihexyphenidyl—Weight decreased—Bleomycin—skin cancer	0.0118	0.0189	CcSEcCtD
Trihexyphenidyl—Nausea—Vismodegib—skin cancer	0.0117	0.0189	CcSEcCtD
Trihexyphenidyl—Agitation—Imiquimod—skin cancer	0.0117	0.0189	CcSEcCtD
Trihexyphenidyl—Dry skin—Temozolomide—skin cancer	0.0116	0.0187	CcSEcCtD
Trihexyphenidyl—CHRM1—head—skin cancer	0.0112	0.0294	CbGeAlD
Trihexyphenidyl—Dry skin—Fluorouracil—skin cancer	0.0107	0.0172	CcSEcCtD
Trihexyphenidyl—Constipation—Vemurafenib—skin cancer	0.0104	0.0168	CcSEcCtD
Trihexyphenidyl—Tachycardia—Imiquimod—skin cancer	0.0101	0.0163	CcSEcCtD
Trihexyphenidyl—CHRM3—head—skin cancer	0.00999	0.0263	CbGeAlD
Trihexyphenidyl—Weight decreased—Temozolomide—skin cancer	0.00991	0.016	CcSEcCtD
Trihexyphenidyl—Somnolence—Imiquimod—skin cancer	0.00924	0.0149	CcSEcCtD
Trihexyphenidyl—Asthenia—Vemurafenib—skin cancer	0.00875	0.0141	CcSEcCtD
Trihexyphenidyl—Hallucination—Temozolomide—skin cancer	0.00873	0.0141	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Imiquimod—skin cancer	0.00857	0.0138	CcSEcCtD
Trihexyphenidyl—Dizziness—Vemurafenib—skin cancer	0.00806	0.013	CcSEcCtD
Trihexyphenidyl—Vomiting—Vemurafenib—skin cancer	0.00775	0.0125	CcSEcCtD
Trihexyphenidyl—Dry skin—Docetaxel—skin cancer	0.00773	0.0124	CcSEcCtD
Trihexyphenidyl—Rash—Vemurafenib—skin cancer	0.00769	0.0124	CcSEcCtD
Trihexyphenidyl—Dermatitis—Vemurafenib—skin cancer	0.00768	0.0124	CcSEcCtD
Trihexyphenidyl—Headache—Vemurafenib—skin cancer	0.00764	0.0123	CcSEcCtD
Trihexyphenidyl—Asthenia—Imiquimod—skin cancer	0.00746	0.012	CcSEcCtD
Trihexyphenidyl—Confusional state—Bleomycin—skin cancer	0.00745	0.012	CcSEcCtD
Trihexyphenidyl—Nausea—Vemurafenib—skin cancer	0.00724	0.0117	CcSEcCtD
Trihexyphenidyl—Vision blurred—Temozolomide—skin cancer	0.0072	0.0116	CcSEcCtD
Trihexyphenidyl—Agitation—Temozolomide—skin cancer	0.00702	0.0113	CcSEcCtD
Trihexyphenidyl—Dizziness—Imiquimod—skin cancer	0.00688	0.0111	CcSEcCtD
Trihexyphenidyl—Vision blurred—Fluorouracil—skin cancer	0.00663	0.0107	CcSEcCtD
Trihexyphenidyl—Vomiting—Imiquimod—skin cancer	0.00661	0.0107	CcSEcCtD
Trihexyphenidyl—Weight decreased—Docetaxel—skin cancer	0.00659	0.0106	CcSEcCtD
Trihexyphenidyl—Rash—Imiquimod—skin cancer	0.00656	0.0106	CcSEcCtD
Trihexyphenidyl—Dermatitis—Imiquimod—skin cancer	0.00655	0.0106	CcSEcCtD
Trihexyphenidyl—Headache—Imiquimod—skin cancer	0.00651	0.0105	CcSEcCtD
Trihexyphenidyl—Confusional state—Temozolomide—skin cancer	0.00628	0.0101	CcSEcCtD
Trihexyphenidyl—Nausea—Imiquimod—skin cancer	0.00618	0.00995	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Bleomycin—skin cancer	0.00609	0.00981	CcSEcCtD
Trihexyphenidyl—Confusional state—Fluorouracil—skin cancer	0.00579	0.00933	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Dactinomycin—skin cancer	0.00568	0.00915	CcSEcCtD
Trihexyphenidyl—Tachycardia—Fluorouracil—skin cancer	0.0056	0.00903	CcSEcCtD
Trihexyphenidyl—Somnolence—Temozolomide—skin cancer	0.00554	0.00892	CcSEcCtD
Trihexyphenidyl—Constipation—Temozolomide—skin cancer	0.00533	0.00858	CcSEcCtD
Trihexyphenidyl—Asthenia—Bleomycin—skin cancer	0.0053	0.00854	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Temozolomide—skin cancer	0.00514	0.00827	CcSEcCtD
Trihexyphenidyl—Somnolence—Fluorouracil—skin cancer	0.0051	0.00822	CcSEcCtD
Trihexyphenidyl—Asthenia—Dactinomycin—skin cancer	0.00494	0.00796	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Fluorouracil—skin cancer	0.00473	0.00762	CcSEcCtD
Trihexyphenidyl—Vomiting—Bleomycin—skin cancer	0.0047	0.00757	CcSEcCtD
Trihexyphenidyl—Rash—Bleomycin—skin cancer	0.00466	0.0075	CcSEcCtD
Trihexyphenidyl—Dermatitis—Bleomycin—skin cancer	0.00465	0.0075	CcSEcCtD
Trihexyphenidyl—Asthenia—Temozolomide—skin cancer	0.00447	0.0072	CcSEcCtD
Trihexyphenidyl—Nausea—Bleomycin—skin cancer	0.00439	0.00707	CcSEcCtD
Trihexyphenidyl—Vomiting—Dactinomycin—skin cancer	0.00438	0.00706	CcSEcCtD
Trihexyphenidyl—Rash—Dactinomycin—skin cancer	0.00434	0.007	CcSEcCtD
Trihexyphenidyl—Confusional state—Docetaxel—skin cancer	0.00418	0.00673	CcSEcCtD
Trihexyphenidyl—Dizziness—Temozolomide—skin cancer	0.00412	0.00664	CcSEcCtD
Trihexyphenidyl—Nausea—Dactinomycin—skin cancer	0.00409	0.00659	CcSEcCtD
Trihexyphenidyl—Tachycardia—Docetaxel—skin cancer	0.00404	0.00652	CcSEcCtD
Trihexyphenidyl—Vomiting—Temozolomide—skin cancer	0.00396	0.00638	CcSEcCtD
Trihexyphenidyl—Rash—Temozolomide—skin cancer	0.00393	0.00633	CcSEcCtD
Trihexyphenidyl—Dermatitis—Temozolomide—skin cancer	0.00393	0.00632	CcSEcCtD
Trihexyphenidyl—Headache—Temozolomide—skin cancer	0.0039	0.00629	CcSEcCtD
Trihexyphenidyl—Dizziness—Fluorouracil—skin cancer	0.0038	0.00612	CcSEcCtD
Trihexyphenidyl—Nausea—Temozolomide—skin cancer	0.0037	0.00596	CcSEcCtD
Trihexyphenidyl—Somnolence—Docetaxel—skin cancer	0.00368	0.00593	CcSEcCtD
Trihexyphenidyl—Vomiting—Fluorouracil—skin cancer	0.00365	0.00588	CcSEcCtD
Trihexyphenidyl—Rash—Fluorouracil—skin cancer	0.00362	0.00583	CcSEcCtD
Trihexyphenidyl—Dermatitis—Fluorouracil—skin cancer	0.00362	0.00583	CcSEcCtD
Trihexyphenidyl—Headache—Fluorouracil—skin cancer	0.0036	0.00579	CcSEcCtD
Trihexyphenidyl—Constipation—Docetaxel—skin cancer	0.00354	0.00571	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Docetaxel—skin cancer	0.00341	0.0055	CcSEcCtD
Trihexyphenidyl—Nausea—Fluorouracil—skin cancer	0.00341	0.00549	CcSEcCtD
Trihexyphenidyl—Asthenia—Docetaxel—skin cancer	0.00297	0.00479	CcSEcCtD
Trihexyphenidyl—Dizziness—Docetaxel—skin cancer	0.00274	0.00441	CcSEcCtD
Trihexyphenidyl—Vomiting—Docetaxel—skin cancer	0.00263	0.00424	CcSEcCtD
Trihexyphenidyl—Rash—Docetaxel—skin cancer	0.00261	0.00421	CcSEcCtD
Trihexyphenidyl—Dermatitis—Docetaxel—skin cancer	0.00261	0.00421	CcSEcCtD
Trihexyphenidyl—Headache—Docetaxel—skin cancer	0.0026	0.00418	CcSEcCtD
Trihexyphenidyl—Nausea—Docetaxel—skin cancer	0.00246	0.00397	CcSEcCtD
